Black Rock Inc. Crinetics Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,436,104 shares of CRNX stock, worth $244 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,436,104

Previous 5,345,114 1.7%

Holding current value

$244 Million

Previous $190 Million 33.8%

% of portfolio

0.01%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$34.76 - $46.81 $3.16 Million - $4.26 Million	90,990 Added 1.7%	5,436,104 $254 Million
Q4 2023 Feb 13, 2024	BUY	$25.62 - $37.07 $12.8 Million - $18.5 Million	499,397 Added 10.31%	5,345,114 $190 Million
Q3 2023 Nov 13, 2023	BUY	$15.97 - $30.59 $3.92 Million - $7.5 Million	245,231 Added 5.33%	4,845,717 $144 Million
Q2 2023 Aug 11, 2023	BUY	$15.73 - $23.6 $10.1 Million - $15.2 Million	644,128 Added 16.28%	4,600,486 $82.9 Million
Q1 2023 May 12, 2023	BUY	$15.31 - $21.1 $595,084 - $820,135	38,869 Added 0.99%	3,956,358 $63.5 Million

Q4 2022 Feb 13, 2023	BUY	$15.49 - $19.05 $2.56 Million - $3.15 Million	165,467 Added 4.41%	3,917,489 $71.7 Million
Q3 2022 Nov 14, 2022	SELL	$18.11 - $22.37 $678,418 - $838,002	-37,461 Reduced 0.99%	3,752,022 $73.7 Million
Q2 2022 Aug 12, 2022	BUY	$16.49 - $27.64 $8.12 Million - $13.6 Million	492,703 Added 14.94%	3,789,483 $70.7 Million
Q1 2022 May 12, 2022	BUY	$17.15 - $28.31 $353,461 - $583,469	20,610 Added 0.63%	3,296,780 $72.4 Million
Q4 2021 Feb 10, 2022	BUY	$19.35 - $28.41 $12.8 Million - $18.7 Million	659,331 Added 25.2%	3,276,170 $93.1 Million
Q3 2021 Nov 09, 2021	BUY	$16.88 - $25.23 $395,886 - $591,719	23,453 Added 0.9%	2,616,839 $55.1 Million
Q2 2021 Aug 11, 2021	BUY	$15.9 - $21.15 $41.2 Million - $54.9 Million	2,593,386 New	2,593,386 $48.9 Million

Others Institutions Holding CRNX

# of Institutions

220

Shares Held

75.8M

Call Options Held

631K

Put Options Held

749K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.41B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account